Back to search results

Observational Study of Biomarkers in Various Diseases

This is an observational study looking at different biological markers (biomarkers) in people with various conditions like cancer (oncology), blood cancers (hematologic malignancy), digestive problems (gastro-intestinal disorder), autoimmune diseases, and pregnancy-related issues, as well as healthy individuals. The study aims to understand the changes in proteins (proteomic) and genes (genomic) that happen in these conditions. There are no interventions or treatments given in this study. Researchers will collect biological samples (biospecimens) like tissue and body fluids, along with your health information. The goal is to discover new biomarkers, develop diagnostic tests, and advance medical research. The study plans to enroll 10,000 participants aged 18 and older.

Study design
This is an observational study, meaning no treatments are given. It aims to enroll 10,000 participants.
What's involved
You would provide biological samples like tissue, whole teeth, and body fluids, along with your clinical data. This would happen on average once per year through study completion.
Compensation
Not stated in the trial record.
Follow-up
Your enrollment and collection totals will be measured through study completion, an average of once per year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05889806

AUD Biomarkers Study (Proteomic and Genomic Analysis of Biospecimens)

Enrolling by Invitation
Not specifiedAges 18+Observational
Audubon Bioscience
~10,000 participants
Updated 2023-06-05 on ClinicalTrials.gov
What's tested:Observational Study Only. NO Intervention.

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Enrollment and collection totals for a diverse population of subjects/conditions involved in diseases and in healthy/control populations.
Measured over Through study completion, an average of once per year

Conditions

Oncology
Hematologic Malignancy
Gastro-Intestinal Disorder
Autoimmune Diseases
Pregnancy Related
Infectious Disease
Cardiovascular Diseases
Genitourinary Disease
Renal Disease

Explore related trials

Autoimmune DiseaseCardiovascular DisorderDigestive System DisorderGenitourinary System DisorderInfectious DisorderMalignant NeoplasmMalignant neoplasm of lymphoid, hematopoietic and/or related tissueNephropathyPregnancy-Related Conditions

NCT05889806

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • AUD

    New Orleans, Louisianano site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

What this trial measures

  • Enrollment and collection totals for a diverse population of subjects/conditions involved in diseases and in healthy/control populations.Through study completion, an average of once per year

    We will total the number of subjects and characterize the totals by disease state, gender, ethnicity and specimens contributed